Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-25
2010-11-30
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S360000, C560S035000, C562S507000, C562S561000
Reexamination Certificate
active
07842684
ABSTRACT:
The present invention provides 2-azetidinone derivatives, or pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof, comprising formula (I):wherein the substituents are as herein defined. The compounds possess cholesterol absorption inhibitory activity and are accordingly of value in the treatment of disease states associated with hyperlipidaemic conditions.
REFERENCES:
patent: 5360817 (1994-11-01), Von Izstein et al.
patent: 5631365 (1997-05-01), Rosenblum et al.
patent: 5661145 (1997-08-01), Davis
patent: 5739321 (1998-04-01), Wu et al.
patent: 5756470 (1998-05-01), Yumibe et al.
patent: 5767115 (1998-06-01), Rosenblum et al.
patent: 5846966 (1998-12-01), Rosenblum et al.
patent: 5886171 (1999-03-01), Wu et al.
patent: 5919672 (1999-07-01), Homann et al.
patent: RE37721 (2002-05-01), Rosenblum et al.
patent: 7470678 (2008-12-01), Starke et al.
patent: 2003/0119428 (2003-06-01), Davis et al.
patent: 2003/0119757 (2003-06-01), Davis
patent: 2004/0018060 (2004-01-01), Knezek
patent: 2004/0018061 (2004-01-01), Jansson
patent: 2004/0254369 (2004-12-01), Framroze
patent: 2005/0096307 (2005-05-01), Graziano
patent: 2005/0267049 (2005-12-01), Goulet et al.
patent: 2006/0046996 (2006-03-01), Aoki et al.
patent: 2006/0069080 (2006-03-01), Veltri
patent: 2007/0049748 (2007-03-01), Uppala et al.
patent: 2007/0078098 (2007-04-01), DeVita et al.
patent: 2007/0129540 (2007-06-01), Framroze
patent: 2008/0064676 (2008-03-01), Alenfalk et al.
patent: 2008/0070890 (2008-03-01), Burnett et al.
patent: 2010/0048529 (2010-02-01), Dahlstrom et al.
patent: 2010/0048530 (2010-02-01), Dahlstrom et al.
patent: 2010/0099657 (2010-04-01), Alenfalk et al.
patent: 2010/0125059 (2010-05-01), Nakano et al.
patent: 2010/0137273 (2010-06-01), Alenfalk et al.
patent: 2010/0152156 (2010-06-01), Dahlstrom et al.
patent: 2010/0168075 (2010-07-01), Dahlstrom et al.
patent: 524595 (1993-01-01), None
patent: 1362855 (2003-11-01), None
patent: 1413331 (2004-04-01), None
patent: 9302048 (1993-02-01), None
patent: 9414433 (1994-07-01), None
patent: 9417038 (1994-08-01), None
patent: 9501961 (1995-01-01), None
patent: 9508532 (1995-03-01), None
patent: 9526334 (1995-10-01), None
patent: 9535277 (1995-12-01), None
patent: 9609827 (1996-04-01), None
patent: 9616037 (1996-05-01), None
patent: 9619450 (1996-06-01), None
patent: 9716424 (1997-05-01), None
patent: 9716455 (1997-05-01), None
patent: 9745406 (1997-12-01), None
patent: 0020623 (2000-04-01), None
patent: 0034240 (2000-06-01), None
patent: 0038725 (2000-07-01), None
patent: 0060107 (2000-10-01), None
patent: 0063703 (2000-10-01), None
patent: 0218432 (2002-03-01), None
patent: 0250027 (2002-06-01), None
patent: 0250060 (2002-06-01), None
patent: 0250068 (2002-06-01), None
patent: 0250090 (2002-06-01), None
patent: 02058685 (2002-08-01), None
patent: 02058696 (2002-08-01), None
patent: 02058731 (2002-08-01), None
patent: 02058732 (2002-08-01), None
patent: 02058733 (2002-08-01), None
patent: 02058734 (2002-08-01), None
patent: 02066464 (2002-08-01), None
patent: 02072104 (2002-09-01), None
patent: 02079174 (2002-10-01), None
patent: 02096415 (2002-12-01), None
patent: 03026643 (2003-04-01), None
patent: 03026644 (2003-04-01), None
patent: 03088962 (2003-10-01), None
patent: 04000803 (2003-12-01), None
patent: 04000804 (2003-12-01), None
patent: 04000805 (2003-12-01), None
patent: 2004005247 (2004-01-01), None
patent: 2004009913 (2004-01-01), None
patent: 2004010948 (2004-02-01), None
patent: 2004010993 (2004-02-01), None
patent: 2004014947 (2004-02-01), None
patent: 2004043456 (2004-05-01), None
patent: 2004043457 (2004-05-01), None
patent: 2004081002 (2004-09-01), None
patent: 2004107958 (2004-12-01), None
patent: 2005000353 (2005-01-01), None
patent: 2005021495 (2005-03-01), None
patent: 2005021497 (2005-03-01), None
patent: 2005033100 (2005-04-01), None
patent: 2005042692 (2005-05-01), None
patent: 2005044256 (2005-05-01), None
patent: 2005047248 (2005-05-01), None
patent: 2005049592 (2005-06-01), None
patent: 2005058316 (2005-06-01), None
patent: 2005061451 (2005-07-01), None
patent: 2005061452 (2005-07-01), None
patent: 2005062824 (2005-07-01), None
patent: 2005062897 (2005-07-01), None
patent: 2005066120 (2005-07-01), None
patent: 2005067903 (2005-07-01), None
patent: 2005069900 (2005-08-01), None
patent: 2005113495 (2005-12-01), None
patent: 2005113496 (2005-12-01), None
patent: 2006017257 (2006-02-01), None
patent: 2006060808 (2006-06-01), None
patent: 2006068990 (2006-06-01), None
patent: 2006072957 (2006-07-01), None
patent: 2006086562 (2006-08-01), None
patent: 2006102674 (2006-09-01), None
patent: 2006107936 (2006-10-01), None
patent: 2006116499 (2006-11-01), None
patent: 2006121861 (2006-11-01), None
patent: 2006122186 (2006-11-01), None
patent: 2006122216 (2006-11-01), None
patent: 2006124713 (2006-11-01), None
patent: 2006127893 (2006-11-01), None
patent: 2006134604 (2006-12-01), None
patent: 2006137080 (2006-12-01), None
patent: 2006137782 (2006-12-01), None
patent: 2006137792 (2006-12-01), None
patent: 2006137793 (2006-12-01), None
patent: 2006137794 (2006-12-01), None
patent: 2006137795 (2006-12-01), None
patent: 2006137796 (2006-12-01), None
patent: 2006137797 (2006-12-01), None
patent: 2006138163 (2006-12-01), None
patent: 2007003365 (2007-01-01), None
patent: 2007008529 (2007-01-01), None
patent: 2007008541 (2007-01-01), None
patent: 2007015161 (2007-02-01), None
patent: 2007016643 (2007-02-01), None
patent: 2007017705 (2007-02-01), None
patent: 2007030721 (2007-03-01), None
patent: 2007058335 (2007-05-01), None
patent: 2007059871 (2007-05-01), None
patent: 2007072088 (2007-06-01), None
patent: 2007075702 (2007-07-01), None
Zaks et al., “Enzymatic glucuronidation of a novel cholesterol absorption inhibitor,” Appl Biochem Biotechnol. (1998) 73 (2-3):205-214.
Groning et al., “Dosage forms with controlled gastrointestinal passage—studies on the absorption of nitrofurantoin,” Int J. Pharm (1989) 56:111-116.
Journal of the American College of Cardiology (2000) 35(1):252A.
Van Heek et al., “Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663,” Br. J. Pharmacol (2000) 129(8):1748-1754.
Wu et al., “A Novel One-Step Diastereo- and Enantioselective Formation of trans-Azetidinones and Its Application to the Total Synthesis of Cholesterol Absorption Inhibitors,” J. Org. Chem (1999) 64:3714-3718.
Vaccaro et al., “Carboxy-substituted 2-azetidinones as cholesterol absorption inhibitors,” Bioorganic & Medicinal Chemistry Letters (1998) 8:319-322.
Rosenblum et al., “Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption.,” J. Med Chem (1998) 41:973-980.
Burnett et al., “2-Azetidinones as Inhibitors of Cholesterol Absorption,” Journal of Medicinal Chemistry (1994) 37 (12):1733-1736.
Sobieszczyk et al., “Acute pulmonary embolism: don't ignore the platelet,” Circulation (2002) 106(14):1748-1749.
Castaner et al., “Ezetimibe Hypolipidemic, Cholesterol absorption inhibitor,” Drugs of the Future (2000) 25(7):679-685.
Vaccaro et al., “Sugar-substituted 2-azetidinone cholesterol absorption inhibitors: Enhanced potency by modification of the sugar,” Bioorganic & Medicinal Chemistry Letters (1998) 8:313-318.
Kirkup et al., “(í)-SCH 57939: synthesis and pharmacological properties of a potent, metabolically stable cholesterol absorption inhibitor,” Bioorganic & Medicinal Chemistry Letters (1996) 6(17):2069-2072.
Fu et al., “Process for preparing Ezetimibe intermediate by an acid enhanced chemo- and enantioselective CBS catalyzed ketone reduction,” Tetrahedron Letters (2003) 44:801-804.
Mounsey et al., “Diet may slow progression of diabetic nephropathy,” The Journal of Family Practice (2003) 52 (9):672-673.
Burnett et a
Lemurell Malin
Starke Ingemar
AstraZeneca AB
Berch Mark L
Pepper Hamilton LLP
LandOfFree
Diphenylazetidinone derivatives possessing cholesterol... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diphenylazetidinone derivatives possessing cholesterol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diphenylazetidinone derivatives possessing cholesterol... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4239375